Samuel S. Ahn

Professional at University Vascular Associates-Westwood, Inc.

Samuel S. Ahn

Samuel S. Ahn

Professional at University Vascular Associates-Westwood, Inc.

Overview
Career Highlights

Vascular Management Associates, Inc.
MediBank International LLC
Wright/Ahn Technologies LLC

RelSci Relationships

93

Number of Boards

1

Birthday

1955

Age

63

Relationships
RelSci Relationships are individuals Samuel S. Ahn likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Northstar Biotech Group LLC

Relationship likelihood: Strong

Doctor at The Mayo Clinic

Relationship likelihood: Strong

Doctor at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Doctor at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Professional at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Professional at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Professional at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Professional at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Professional at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Professional at University Vascular Associates-Westwood, Inc.

Relationship likelihood: Strong

Paths to Samuel S. Ahn
Potential Connections via
Relationship Science
You
Samuel S. Ahn
Professional at University Vascular Associates-Westwood, Inc.
Education
Class of 2004

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.

Class of 1978

The University of Texas at Austin is one of the largest public universities in the United States and is the largest institution of The University of Texas System. Founded in 1883, the university has grown from a single building, eight teachers, two departments and 221 students to a 350-acre main campus with 17 colleges and schools, about 24,000 faculty and staff, and more than 50,000 students.

UT Southwestern Medical Center is distinctive for its overall quality and for the strength of its three core missions of education, research, and patient care. These mission components are highly interdependent; each is integral to and enhances the others.UT Southwestern consists today of three degree-granting schools and a University Health System of hospitals and clinics. Its faculty is renowned for including six Nobel Laureates (one now Emeritus) and many members of the National Academy of Sciences and Institute of Medicine, and UT Southwestern Medical Center is either nationally ranked or rated as high performing in nearly a dozen specialties by U.S. News & World Report.

Career History
Professional
2006 - Current

University Vascular Associates-Westwood, Inc. provides diagnosis and treatment of peripheral vascular and other vascular-related diseases. It treats patients with the following conditions: peripheral arterial disease, abdominal aortic aneurysms, ulcerations and gangrene of the lower extremities, carotid artery disease, atherosclerosis, abdominal and renal vascular diseases, thoracic outlet syndrome, and varicose veins. The company was founded by Samuel S. Ahn and is headquartered in Los Angeles, CA.

Co-Founder
2009 - Prior
Co-Founder
2008 - Prior
Boards & Committees
Member, Board of Directors
2010 - Prior

U.S. Stem Cell, Inc. is a biotechnology company, which focuses on the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its product MyoCell, deals with the clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company was founded by Howard J. Leonhardt and Robert D. Lashinski on August 12, 1999 and is headquartered in Sunrise, FL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Samuel S. Ahn. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Samuel S. Ahn's profile does not indicate a business or promotional relationship of any kind between RelSci and Samuel S. Ahn.